Latest Europe News

Euro Manganese has confirmed no material changes in its operations amid recent spikes in market activity, reassuring investors and regulators alike.

Brazilian Critical Minerals has reported significant progress at its Ema rare earths project, producing a high-grade rare earth carbonate rich in critical magnet metals and advancing key drilling, permitting, and feasibility milestones.

The Swedish Government has formally approved the detailed zoning plan for Talga Group’s Nunasvaara South Graphite Mine, clearing a major regulatory hurdle and advancing the Vittangi Anode Project towards commercial production.

Nordic Resources has expanded its Kopsa gold-copper project in Finland through an upsized drilling program, confirming significant new mineralised zones and securing over A$10 million in institutional funding.

European Resources Limited has accelerated its rare earths exploration and metallurgical programs in Finland, supported by a fully subscribed $1.6 million rights issue and a $546,750 placement. Key drilling and processing initiatives aim to unlock value amid rising global demand for critical minerals.

Rhythm Biosciences has begun commercialising its blood-based colorectal cancer test, ColoSTAT®, following key accreditations and validation. The company also secured a strategic partnership with NHS England and expanded its geneType™ platform globally.

Cambium Bio has strengthened its financial footing with a $0.6 million R&D tax refund and a $2.4 million strategic placement, setting the stage for pivotal Phase 3 clinical trials of its lead ophthalmology candidate.

Ballard Mining has raised $61 million through a well-supported placement to fund an aggressive drilling program and early development works at its Mt Ida Gold Project, positioning the company for a Final Investment Decision.

Anteris Technologies Global Corp. has launched a $230 million equity offering alongside an $84 million private placement with Medtronic’s subsidiary, aiming to accelerate clinical trials and scale manufacturing of its innovative DurAVR Transcatheter Heart Valve.

Memphasys Limited has achieved its first material revenues following CE Mark approval for its Felix™ System, activating multi-year contracts across Europe, the Middle East, and Asia. The company is now transitioning from regulatory preparation to global commercial rollout with a focus on recurring revenues.

Norwood Systems has reported a record preliminary revenue of $2.1 million for the first half of FY2026, driven by milestone payments from Optus and a successful Tier-1 APAC proof-of-concept. The company is progressing multiple global telco engagements and strengthening strategic partnerships with Microsoft and AWS.

Osteopore Limited has inked a three-year exclusive distribution agreement with MontsMed to introduce its advanced orthopaedic trauma reconstruction products into Hong Kong, positioning itself strategically within the Greater Bay Area.